Repeated Examinations for Typing Pulmonary Embolism
Recruiting
Observational Study
Pulmonary Embolism (Diagnosis)
Pulmonary Embolism Acute
Pulmonary Embolism With Acute Cor Pulmonale
Pulmonary Embolism With Right Ventricle Enlargement
Pulmonary Embolism (PE)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 400 (estimated)
- Sponsor
- Sahlgrenska University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
PURPOSE
The two related purposes of the RE-TyPE study are:
1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and
2. To establish a platform for longitudinal follow-up for all pulmonary embolism at Sahlgrenska University Hospital
HYPOTHESES
1. The dynamic pattern of change, evaluated thorough repeated measures …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Adult patients (≥ 18 years old) who is diagnosed with, or followed as out-patients for, PE at Sahlgrenska University Hospital
2. Written informed consent
Exclusion Criteria from Cohort A:
1. Low risk, intermediate-low risk or high risk PE\*
2. \>48 hours since arrival to ho…
Contacts
Mazdak Tavoly, MD, PhD
+46313421000
CONTACT